TBPH
Theravance Biopharma Inc
Price:  
8.48 
USD
Volume:  
391,117.00
Cayman Islands | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TBPH WACC - Weighted Average Cost of Capital

The WACC of Theravance Biopharma Inc (TBPH) is 6.9%.

The Cost of Equity of Theravance Biopharma Inc (TBPH) is 9.00%.
The Cost of Debt of Theravance Biopharma Inc (TBPH) is 5.00%.

Range Selected
Cost of equity 6.90% - 11.10% 9.00%
Tax rate 1.30% - 2.40% 1.85%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.9% - 8.0% 6.9%
WACC

TBPH WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.66 1.1
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 11.10%
Tax rate 1.30% 2.40%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.9% 8.0%
Selected WACC 6.9%